What are the risks of premature ovarian failure (POF) or induced menopause due to surgery at age 32?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Premature ovarian failure (POF) or induced menopause due to surgery at age 32 poses significant risks, including immediate menopausal symptoms and long-term consequences such as increased risk of cardiovascular disease, osteoporosis, and neurocognitive effects.

Risks and Consequences

  • The risks associated with POF or induced menopause include:
    • Immediate menopausal symptoms: vasomotor symptoms, mood changes, sleep disturbance, vaginal dryness, and sexual dysfunction 1
    • Long-term consequences: increased risk of cardiovascular disease, osteoporosis, and neurocognitive effects 1
  • Hormone replacement therapy (HRT) is recommended to alleviate symptoms and minimize long-term effects, but it may not completely ameliorate the effects of surgery on sexual function 1

Management and Prevention

  • HRT should be considered until at least the average age of natural menopause (around 51 years), in the absence of contraindications such as personal history of breast cancer or venous thromboembolism 1
  • For women who are not having a hysterectomy, oestrogen must be used in combination with a progestogen to protect against endometrial cancer 1
  • The intra-uterine system can be placed at the time of surgery to deliver progestogen directly into the uterus, with fewer adverse effects than systemic progestogen 1

Individualized Approach

  • The decision to undergo risk-reducing surgery should be individualized, taking into account the woman's age, childbearing status, and personal circumstances 1
  • Women with moderate-to-high-risk germline pathogenic variants should be offered the option of fertility preservation with IVF or oocyte freezing before undergoing surgery 1

From the Research

Risks of Premature Ovarian Failure (POF) or Induced Menopause due to Surgery at Age 32

  • The risks of premature ovarian failure (POF) or induced menopause due to surgery at age 32 include a sudden reduction of ovarian sex steroid production, which can lead to premature ovarian insufficiency 2.
  • Surgical menopause at any age is not associated with an increased risk of dementia, but early surgical menopause (≤45 years of age) is associated with a higher risk of dementia and cognitive decline 3.
  • Premature ovarian failure (POF) is a primary ovarian defect characterized by absent menarche or premature depletion of ovarian follicles before the age of 40 years, and it can lead to infertility, neurological, metabolic, or cardiovascular consequences, and early onset of osteoporosis 4.
  • Premature ovarian insufficiency (POI) has been associated with neurological dysfunction and an increased risk of dementia, perhaps due to depletion in estrogen levels, and the risk appears to be most apparent on domains of global cognitive and verbal memory tests 5.
  • Treatment of POF is based on hormonal replacement therapy to avoid estrogen deficiency, suppress vasomotor symptoms, and avoid bone loss as well as cardiovascular risk, and patients with POF should be informed that spontaneous pregnancies may occur and should be oriented to a specialized unit for in vitro fertilization with oocyte donation if desired 6.

Potential Consequences of Induced Menopause at Age 32

  • Induced menopause at age 32 can lead to a range of consequences, including:
    • Infertility
    • Neurological dysfunction
    • Increased risk of dementia
    • Cognitive decline
    • Early onset of osteoporosis
    • Cardiovascular risk
    • Emotional distress and depression
    • Hormonal imbalance 2, 3, 4, 5, 6

Importance of Hormone Replacement Therapy (HRT)

  • HRT is essential for women who have undergone surgical menopause, including those who have had bilateral salpingo-oophorectomy (BSO) before the natural age of menopause 2.
  • HRT should be considered until the natural age of menopause at least, and should include consideration of androgen to address sexual function and sexual desire alterations 2.
  • HRT can help to alleviate symptoms of estrogen deficiency, suppress vasomotor symptoms, and avoid bone loss as well as cardiovascular risk 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The surgical menopause.

Best practice & research. Clinical obstetrics & gynaecology, 2022

Research

Premature ovarian failure.

Orphanet journal of rare diseases, 2006

Research

[Premature ovarian failures].

Presse medicale (Paris, France : 1983), 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.